CJC-1295 DAC (Research-Grade Long-Acting GHRH Analog)
For Laboratory Use Only – Not for Human or Veterinary Application
Product Overview
CJC-1295 DAC is a synthetic, long-acting analog of Growth Hormone Releasing Hormone (GHRH), engineered to extend its circulating half-life and support stable plasma levels in controlled research settings. The Drug Affinity Complex (DAC) modification allows for sustained GH release, facilitating studies into somatotropic axis regulation, IGF-1 signal modulation, and extended endocrine feedback mechanisms.
This compound is not approved for clinical, therapeutic, or veterinary applications.
Compound Profile
Attribute | Details |
---|---|
Contents | 5 mg CJC-1295 DAC (lyophilized powder) |
Purity | ≥98% (HPLC-verified) |
Format | Sterile, freeze-dried vial |
Storage | Store at –20 °C in a moisture-free, dark environment |
Reconstitution | Reconstitute with sterile bacteriostatic water (0.9% NaCl) under aseptic conditions |
Intended Use | Laboratory and preclinical research only |
Key Research Applications
CJC-1295 DAC has been evaluated in preclinical models for its potential role in:
- Extended Growth Hormone Release Models
- Investigation of sustained GH elevation over several days
- IGF-1 Signal Modulation and Timing
- Studies examining prolonged IGF-1 response patterns
- Musculoskeletal Recovery Research
- Research into anabolic signaling pathways and tissue remodeling processes
- Endocrine System Feedback Analysis
- Modeling hypothalamic-pituitary axis adaptations to sustained GH stimulation
The DAC modification extends half-life up to approximately 8 days in non-human models, reducing dosing frequency for longitudinal research and distinguishing it from “No DAC” variants, which maintain pulsatile GH dynamics.
Mechanism of Action (Preclinical Models)
- Selective binding to GHRH receptors in the anterior pituitary
- Induction of GH secretion in a sustained, non-pulsatile manner
- Support for prolonged IGF-1 elevation in models requiring continuous endocrine signaling
Handling & Reconstitution
- Reconstitute using sterile bacteriostatic water (0.9% sodium chloride) under aseptic technique
- Store reconstituted solution at 2–8 °C and use according to institutional guidelines
- Avoid repeated freeze-thaw cycles to preserve peptide integrity
Regulatory and Compliance Notice
- Research Use Only: For use by qualified laboratory personnel exclusively
- Not FDA Approved: No therapeutic, diagnostic, or efficacy claims are made
- Not for Human or Veterinary Use: Do not inject, ingest, or apply to living organisms
- Regulatory Responsibility: Researchers must comply with institutional, local, and federal regulations
Misuse of this compound may contravene federal or state laws. Usage is restricted to qualified laboratories operating under approved research protocols.
Quality Assurance
CJC-1295 DAC is manufactured by HVY Research under controlled sterile conditions with routine batch verification. Researchers are required to adhere to standard laboratory safety protocols, including personal protective equipment (PPE).
Disclaimer
This product is intended strictly for research purposes. It is not approved for clinical, therapeutic, or diagnostic applications, nor for human or animal consumption. Information provided is solely for scientific reference.
There are no reviews yet.